Reassessing the Risks and Benefits of Thiopurines in Crohn's Disease
An editorial in the April issue of CGH takes a new look at the risks and benefits of thiopurines in treating Crohn's disease. Dr. Kuemmerle speaks to Dr. Stephen B. Hanauer of the University of Chicago Medical Center (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - April 4, 2013 Category: Gastroenterology Authors: AGA Source Type: podcasts
Colorectal Neoplasia Risk in Patients with Colonic Crohn's Disease and Concomitant Primary Sclerosing Cholangitis
A study in the March issue of CGH looks at whether primary sclerosing cholangitis is also a risk factor for colorectal dysplasia or cancer in patients with Crohn's disease of the colon. Dr. Kuemmerle speaks with senior author Dr. Roger Chapman (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - March 1, 2012 Category: Gastroenterology Authors: AGA Source Type: podcasts
Adverse Events Do Not Outweigh Benefits of Combination Therapy for Crohn's Disease in a Decision Analytic Model
. Dr. Kuemmerle speaks to the first author of this study in the January issue of CGH, Dr. Corey Siegel. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - December 22, 2011 Category: Gastroenterology Authors: AGA Source Type: podcasts
Symptoms May Not Indicate Failure of Anti–Tumor Necrosis Factor Therapy in Crohn's Disease
A Perspective article in the May issue of CGH examines the challenges of monitoring patients with Crohn's disease who remain symptomatic despite anti–tumor necrosis factor therapy. Dr. Kuemmerle speaks to author Dr. William Sandborn (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - May 6, 2011 Category: Gastroenterology Authors: AGA Source Type: podcasts
Symptoms May Not Indicate Failure of Anti –Tumor Necrosis Factor Therapy in Crohn's Disease
A Perspective article in the May issue of CGH examines the challenges of monitoring patients with Crohn's disease who remain symptomatic despite anti –tumor necrosis factor therapy. Dr. Kuemmerle speaks to author Dr. William Sandborn (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - May 6, 2011 Category: Gastroenterology Authors: AGA Source Type: podcasts
Anti–Tumor Necrosis Factor Therapy in Crohn's Disease
An editorial in the July issue of CGH summarizes current information and questions about anti–tumor necrosis factor therapy in Crohn's disease. Dr. Kuemmerle speaks to author Dr. Charles N. Bernstein of the University of Manitoba. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 29, 2010 Category: Gastroenterology Authors: AGA Source Type: podcasts
Anti –Tumor Necrosis Factor Therapy in Crohn's Disease
An editorial in the July issue of CGH summarizes current information and questions about anti –tumor necrosis factor therapy in Crohn's disease. Dr. Kuemmerle speaks to author Dr. Charles N. Bernstein of the University of Manitoba. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 29, 2010 Category: Gastroenterology Authors: AGA Source Type: podcasts
Risk of Lymphoma Associated With Combination Anti –Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease
Dr. Bruce Sands looks at the rate of non-Hodgkin's lymphoma in adult Crohn's disease patients who have received anti-TNF therapy, compared with that of a population-based registry and a populationof CD patients treated with immunomodulators. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 29, 2009 Category: Gastroenterology Authors: AGA Source Type: podcasts
Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease
Dr. Bruce Sands looks at the rate of non-Hodgkin's lymphoma in adult Crohn's disease patients who have received anti-TNF therapy, compared with that of a population-based registry and a populationof CD patients treated with immunomodulators. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 29, 2009 Category: Gastroenterology Authors: AGA Source Type: podcasts
May 2009: Articles published in this month's issue are discussed
ARTICLES DISCUSSED: Utilization of imaging in pregnant patients: 10-year review of 5270 examinations in 3285 patients—1997–2006. Radiology 2009;251(2):517–524, Carotid artery senosis: accuracy of noninvasive tests—individual patient data meta-analysis. Radiology 2009;251(2):493–502, Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with andiogenesis and inflammation at histologic examination—pilot study. Radiology 2009;251(2):369–379 (Source: Radiology Podcasts)
Source: Radiology Podcasts - May 1, 2009 Category: Radiology Authors: webmaster at rsna.org Tags: Podcasts Source Type: podcasts
May 2009: Obstetric Imaging, Neuroradiology, and Gastrointestinal Imaging studies are discussed
ARTICLES DISCUSSED: Utilization of imaging in pregnant patients: 10-year review of 5270 examinations in 3285 patients—1997–2006. Radiology 2009;251(2):517–524, Carotid artery senosis: accuracy of noninvasive tests—individual patient data meta-analysis. Radiology 2009;251(2):493–502, Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with andiogenesis and inflammation at histologic examination—pilot study. Radiology 2009;251(2):369–379 (Source: Radiology Podcasts)
Source: Radiology Podcasts - May 1, 2009 Category: Radiology Authors: webmaster at rsna.org Tags: Podcasts Source Type: podcasts
